Status:

COMPLETED

Epidural Steroid Injection Versus Epidural Steroid Injection and Manual Physical Therapy and Exercise in the Management of Lumbar Spinal Stenosis

Lead Sponsor:

Franklin Pierce University

Collaborating Sponsors:

University of Colorado, Denver

Conditions:

Lumbar Spinal Stenosis

Eligibility:

All Genders

50-90 years

Phase:

NA

Brief Summary

Lumbar spinal stenosis (LSS) is a prevalent and disabling condition in the rapidly growing aging population. People with LSS often have a substantial physical and psychosocial burden as well as signif...

Eligibility Criteria

Inclusion

  • Lumbar spinal stenosis unidentified by MRI or CT scan and interpreted by a radiologist independent of the study. The criteria of Boden et al will be used to define LSS on MRI: non-discogenic loss of signal in the epidural fat with compression of neural tissues.
  • Chief complaint of pain in the low back, buttock, and/or lower extremity. The patient must have LE symptoms consistent with neurogenic claudiation.
  • Patient-reported inability to walk greater than ¼ mile due to lower extremity pain and/or cramping.
  • Rates sitting as a better position with respect to symptom severity compared to standing or walking.
  • Consent of the patient to undergo education, epidural steroid injection(s), and attend specified physical therapy sessions.
  • Individuals with no language barrier, that are cooperative, have transportation to the Spine Center, and who sign an informed consent form.
  • Age greater than or equal to 50 years.

Exclusion

  • Patients with organic brain syndrome or dementia.
  • Severe vascular, pulmonary or coronary artery disease which limits ambulation.
  • Recent myocardial infarction (within last 6 months).
  • Spondylolisthesis requiring surgical fusion (i.e., greater than 5mm of slippage).
  • Previous spinal surgery that included fusion of two or more vertebrae.
  • Severe osteoporosis as defined by multiple compression fractures or a fracture at the same level as the stenosis.
  • Metastatic cancer.
  • Excessive alcohol consumption or evidence of non-prescribed or illegal drug use.

Key Trial Info

Start Date :

April 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2018

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT00786981

Start Date

April 1 2009

End Date

December 1 2018

Last Update

July 31 2019

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Colorado University

Denver, Colorado, United States

2

Illinois Neurological Institute at OSF

Peoria, Illinois, United States, 61637

3

Keesler Air Force Base

Keesler Air Force Base, Mississippi, United States, 39564

4

Hawkins Foundation

Greenville, South Carolina, United States, 29615